Shinpoong PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Shinpoong PharmaceuticalLtd has a total shareholder equity of ₩268.7B and total debt of ₩44.0B, which brings its debt-to-equity ratio to 16.4%. Its total assets and total liabilities are ₩340.8B and ₩72.2B respectively.
Key information
16.4%
Debt to equity ratio
₩44.00b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩59.08b |
| Equity | ₩268.68b |
| Total liabilities | ₩72.15b |
| Total assets | ₩340.83b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A019175's short term assets (₩194.3B) exceed its short term liabilities (₩69.4B).
Long Term Liabilities: A019175's short term assets (₩194.3B) exceed its long term liabilities (₩2.8B).
Debt to Equity History and Analysis
Debt Level: A019175 has more cash than its total debt.
Reducing Debt: A019175's debt to equity ratio has reduced from 49.8% to 16.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A019175 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A019175 has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 40.2% each year.